Company: LHI
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006939
Chunk: 32

Company: Living Homeopathy International Ltd.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 32
---
 reputation, business, financial condition
or results of operations. We have been subject to negative publicity from time to time, including negative publicity on our product,
LIVING Colloidal Silver, and cannot rule out the possibility of future negative publicity on this and all of our other products, whether
or not accurate. For example, the Hong Kong Department of Health issued a press release on February 27, 2023 on a case of silver poisoning
involving a senior female customer who allegedly had a history of consuming Living Colloidal, and reminds the public of not consuming
products containing colloidal silver. We immediately terminated the sales of LIVING Colloidal Silver for human use. If any human consumption
of LIVING Colloidal Silver results in silver poisoning or other harmful side effects, consumers may bring legal actions against us for
damages and regulators may bring investigations or other proceedings against us which may result in our exposure to monetary and non-monetary
penalties. If so, our reputation, business growth, financial condition and results of operations will be materially and adversely affected.
Even if we are found not at fault in these legal actions or proceedings, we will have to put in substantial financial resources and managerial
attention to deal with these legal actions and proceedings, which otherwise can be applied toward our business development. As of the
date of this prospectus, we are not aware of any complaints, claims, regulator inquiries or legal proceeding relating to Living Colloidal
Silver, which, however, if occurs, will adversely affect our business, financial condition and results of operations. Any negative publicity
on us or any of our products could have a material adverse effect on our reputation and the sales of our products, which could further
materially and adversely affect our business, financial condition and results of operations.

Our business is heavily regulated and our industry may be subject to increasingly tightened regulatory requirements and scrutiny in the main markets where we operate and the new markets we will sell our products, which could potentially adversely affect our business growth, financial condition and results of operations.

As of the date of this prospectus, our primary operations are based
in Hong Kong. Our business is heavily regulated in Hong Kong and must comply with applicable laws and regulations, including the need
to obtain certain licenses and permits. For example, we are required to comply with the Food Safety Ordinance (Chapter 612 of the Laws
of Hong Kong) and be registered as a food importer/distributor under the Food Safety to be able to import health supplements